PHARMACEUTICAL PROTEINS, HUMAN THERAPEUTICS, HUMAN SERUM ALBUMIN INSULIN, NATIVE CHOLERA TOXIN B SUBUNIT ON TRANSGENIC PLASTIDS
This invention relates in part to synthesizing high value pharmaceutical proteins in transgenic plants by chloroplast expression for pharmaceutical protein production. We use poly(GVGVP), for example, as a fusion protein to enable hyper-expression of insulin and to accomplish rapid one step purification of fusion peptides utilizing the inverse temperature transition properties of this polymer. We also use insulin-CTB fusion protein in chloroplasts of nicotine free edible tobacco (LAMD 605) for oral delivery. This invention includes expression of native cholera toxin B subunit gene as oligomers in transgenic tobacco chloroplasts which may be utilized in connection with large-scale production of purified CTB, as well as an edible vaccine if expressed in an edible plant, as a transmucosal carrier of peptides to which it is fused to enhance mucosal immunity, and/or to induce oral tolerance of the products of these peptides. The present invention also relates in part to recombinant DNA vectors for enhanced expression of human serum albumin, insulin-like growth factor I, and interferon-α 2 and 5, via chloroplast genomes.
1 - 12 . (canceled)
13 . A plant plastid that stably produces a cholera toxin B (CTB) fusion protein, said plastid comprising a plastid genome stably transformed by an expression vector comprising, as operably linked components, a first flanking sequence, at least one regulatory sequence operable in a plastid, a heterologous DNA sequence coding for said CTB fusion protein, and a second flanking sequence, wherein said first and second flanking sequences include sequences homologous to a transcriptionally active spacer sequence of the plastid genome such that said heterologous DNA sequence is introduced into said active spacer sequence through homologous recombination, wherein said spacer sequences occur between trnI and trnA in the chloroplast genome.
14 . The plant plastid of claim 1 that stably produces e said CTB fusion protein comprising a plastid genome comprising, as operably linked components in the 5′ to the 3′ direct of translation, a promoter operative in said plastid, a selectable marker sequence, a heterologous DNA sequence coding for said fusion protein, a transcription termination region functional in said plastid, and flanking DNA sequences.
15 . A stable plastid transformation and expression vector as claimed in claim 13 , competent for stably transforming a plastid genome which comprises an expression cassette wherein said heterolgous DNA sequence encoding said fusion protein encodes CTB fused to a protein of interest, a transcription termination region functional in said plastid, and flanking DNA sequences on each side of the expression cassette.
16 . A plant comprising a plurality of plastids of claim 13 , wherein said plant thereby produces said CTB fusion protein.
17 . A plant comprising a plurality of plastids of claim 14 , wherein said plant thereby produces said fusion protein.
18 . A plant comprising a plurality of plastids comprising the vector of claim 15 , wherein said plant thereby produces said protein.
19 . A seed of the plant of claim 18 , said seed comprising said DNA sequence.
20 . A leaf of the plant of claim 18 .
21 . The plant of claim 18 , wherein said plant is a tobacco plant.
22 . The plastid of claim 13 , wherein said plastid is a chloroplast.
23 . A method for producing a CTB fusion protein, said method comprising growing the plant of claim 18 to thereby produce said CTB fusion protein, and extracting and purifying said CTB fusion protein from leaves of said plant.
13 . A plant comprising a plurality of plastids of claim 14 , wherein said plant thereby produces said CTB fusion protein.